Abstract
This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer
Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer
treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. The
report provides separate comprehensive analytics for the US, Europe and Rest
of World. Annual forecasts are provided for each region for the period 2005
through 2015. The report profiles 191 companies including many key and niche
players worldwide such as AstraZeneca PLC., Bristol-Myers Squibb Co., Eli
Lilly & Co., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline Plc.,
Novartis Pharmaceuticals Corporation, OSI Pharmaceuticals, Inc.,
Sanofi-Aventis, AbGenomics International Inc., ImClone Systems, Inc., Pfizer,
Inc., Merck Serono International S.A., Merck & Co. Ltd., Telik, Inc., and
Woomera Therapeutics, Inc. Market data and analytics are derived from primary
and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
| 
View Cart
